Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2025-12-24 @ 11:08 PM
NCT ID:
NCT00430469
Eligibility Criteria:
Inclusion Criteria:
Recipients will be eligible for inclusions if they satisfy the following conditions:
* Has been admitted for an autologous HSCT after myeloablative therapy with high-dose melphalan;
* Is being managed with a 3 or 4-lumen central venous catheter;
* Is at least 18 years old;
* Has a BMI \<30 kg/M2;
* Has no medical reason for not participating
* Has adequate renal function (creatinine \< 1.5 x ULN)
* Has adequate liver function (ASAT, ALAT \< 2.5 x ULN, bilirubin \< 1.5 x ULN);
* If a woman, is functionally post-menopausal
* Has not participated in a study of a new chemical molecular entity in the previous 3 months
* Is able and willing to participate;
* Has provided written informed consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00430469
Study Brief:
Protocol Section:
NCT00430469